From: Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes
Variables (mg/dL) | Control | T2DM | CVD | CVD + T2DM+ | ||||
---|---|---|---|---|---|---|---|---|
E3/E3 | ε4 | E3/E3 | ε4 | E3/E3 | ε4 | E3/E3 | ε4 | |
TC | 4.30 ± 1.36 | 4.35 ± 1.19 | 5.58 ± 1.56 | 5.73 ± 2.03 | 4.98 ± 1.17 | 5.38 ± 1.21* | 4.97 ± 1.36 | 5.20 ± 1.30 |
TG | 1.53 ± 1.60 | 1.73 ± 1.65 | 2.51 ± 3.40 | 3.23 ± 3.81 | 1.40 ± 0.82 | 1.98 ± 1.33** | 2.12 ± 1.49 | 2.81 ± 2.17** |
LDL-C | 2.31 ± 0.91 | 2.39 ± 0.91 | 3.15 ± 1.00 | 3.12 ± 1.35 | 2.81 ± 0.90 | 3.10 ± 0.84* | 2.71 ± 1.00 | 2.99 ± 0.97 |
HDL-C | 1.25 ± 0.43 | 1.24 ± 0.37 | 1.27 ± 0.36 | 1.19 ± 0.29 | 1.32 ± 0.32 | 1.23 ± 0.35 | 1.21 ± 0.29 | 1.09 ± 0.35** |
ApoA1 | 1.03 ± 0.33 | 1.09 ± 0.28 | 1.18 ± 0.34 | 1.13 ± 0.28 | 1.13 ± 0.27 | 1.05 ± 0.28 | 1.14 ± 0.32 | 1.02 ± 0.29* |
ApoB | 0.72 ± 0.26 | 0.77 ± 0.33 | 0.97 ± 0.31 | 0.99 ± 039 | 0.83 ± 0.27 | 0.88 ± 0.22* | 0.88 ± 0.30 | 0.93 ± 0.32 |